Otsuka Pharmaceuticals is collaborating with Health Innovation Oxford HIN to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support the treatment of major depressive disorder (MDD).
Cresset, a provider of integrated in silico solutions for drug discovery announces the release of V9 - the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark.
The continued growth in demand for mini tablets (micro-tablets or mini-tabs) is hardly surprising given the benefits that they can deliver for healthcare professionals and their patients. Their
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways.
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability.
Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, has announced that NICE has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England.
Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem, a family-owned company with decades of extensive experience and expertise in the global pharmaceutical industry.
This GLP-1R / CRE Luciferase Reporter HEK293 cell line has been engineered to monitor activation of GLP-1R in cells by measuring luciferase activity, making it useful for cell-based binding assays and screening for human GLP-1R agonists.
Dr Maxim Polyakov, Senior Vice President, Business Intelligence and Research at M3 discusses how to use primary market research for robust digital marketing.
